Immunometabolic and Lipidomic Markers Associated With the Frailty Index and Quality of Life in Aging HIV+ Men on Antiretroviral Therapy

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

Chronic immune activation persists despite antiretroviral therapy (ART) in HIV+ individuals and underpins an increased risk of age-related co-morbidities. We assessed the Frailty Index in older HIV+ Australian men on ART. Immunometabolic markers on monocytes and T cells were analyzed using flow cytometry, plasma innate immune activation markers by ELISA, and lipidomic profiling by mass spectrometry. The study population consisted of 80 HIV. + men with a median age of 59 (IQR, 56-65), and most had an undetectable viral load (92%). 24% were frail, and 76% were non-frail. Frailty was associated with elevated Glucose transporter-1 (Glut1) expression on the total monocytes (p = 0.04), increased plasma levels of innate immune activation marker sCD163 (OR, 4.8; CI 1.4-15.9, p = 0.01), phosphatidylethanolamine PE(36:3) (OR, 5.1; CI 1.7-15.5, p = 0.004) and triacylglycerol TG(16:1_18:1_18:1) (OR, 3.4; CI 1.3-9.2, p = 0.02), but decreased expression of GM3 ganglioside, GM3(d18:1/18:0) (OR, 0.1; CI 0.0-0.6, p = 0.01) and monohexosylceramide HexCerd(d18:1/22:0) (OR, 0.1; CI 0.0-0.5, p = 0.004). There is a strong inverse correlation between quality of life and the concentration of PE(36:3) (ρ = -0.33, p = 0.004) and PE(36:4) (ρ = -0.37, p = 0.001). These data suggest that frailty is associated with increased innate immune activation and abnormal lipidomic profile. These markers should be investigated in larger, longitudinal studies to determine their potential as biomarkers for frailty.

Original languageEnglish
Pages (from-to)112-121
Number of pages10
JournalEBioMedicine
Volume22
DOIs
Publication statusPublished - Aug 2017

Keywords

  • Aging
  • Frailty
  • Glut1
  • HIV
  • Immunometabolism
  • Inflammation
  • Lipids
  • Metabolism
  • Monocytes

Cite this

@article{3205da672ede47f0bff41b2d70fafc2e,
title = "Immunometabolic and Lipidomic Markers Associated With the Frailty Index and Quality of Life in Aging HIV+ Men on Antiretroviral Therapy",
abstract = "Chronic immune activation persists despite antiretroviral therapy (ART) in HIV+ individuals and underpins an increased risk of age-related co-morbidities. We assessed the Frailty Index in older HIV+ Australian men on ART. Immunometabolic markers on monocytes and T cells were analyzed using flow cytometry, plasma innate immune activation markers by ELISA, and lipidomic profiling by mass spectrometry. The study population consisted of 80 HIV. + men with a median age of 59 (IQR, 56-65), and most had an undetectable viral load (92{\%}). 24{\%} were frail, and 76{\%} were non-frail. Frailty was associated with elevated Glucose transporter-1 (Glut1) expression on the total monocytes (p = 0.04), increased plasma levels of innate immune activation marker sCD163 (OR, 4.8; CI 1.4-15.9, p = 0.01), phosphatidylethanolamine PE(36:3) (OR, 5.1; CI 1.7-15.5, p = 0.004) and triacylglycerol TG(16:1_18:1_18:1) (OR, 3.4; CI 1.3-9.2, p = 0.02), but decreased expression of GM3 ganglioside, GM3(d18:1/18:0) (OR, 0.1; CI 0.0-0.6, p = 0.01) and monohexosylceramide HexCerd(d18:1/22:0) (OR, 0.1; CI 0.0-0.5, p = 0.004). There is a strong inverse correlation between quality of life and the concentration of PE(36:3) (ρ = -0.33, p = 0.004) and PE(36:4) (ρ = -0.37, p = 0.001). These data suggest that frailty is associated with increased innate immune activation and abnormal lipidomic profile. These markers should be investigated in larger, longitudinal studies to determine their potential as biomarkers for frailty.",
keywords = "Aging, Frailty, Glut1, HIV, Immunometabolism, Inflammation, Lipids, Metabolism, Monocytes",
author = "Yeoh, {Hui Ling} and Cheng, {Allen C.} and Cherry, {Catherine L.} and Weir, {Jacquelyn M} and Meikle, {Peter J.} and Hoy, {Jennifer F.} and Crowe, {Suzanne M.} and Palmer, {Clovis S.}",
year = "2017",
month = "8",
doi = "10.1016/j.ebiom.2017.07.015",
language = "English",
volume = "22",
pages = "112--121",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier",

}

TY - JOUR

T1 - Immunometabolic and Lipidomic Markers Associated With the Frailty Index and Quality of Life in Aging HIV+ Men on Antiretroviral Therapy

AU - Yeoh, Hui Ling

AU - Cheng, Allen C.

AU - Cherry, Catherine L.

AU - Weir, Jacquelyn M

AU - Meikle, Peter J.

AU - Hoy, Jennifer F.

AU - Crowe, Suzanne M.

AU - Palmer, Clovis S.

PY - 2017/8

Y1 - 2017/8

N2 - Chronic immune activation persists despite antiretroviral therapy (ART) in HIV+ individuals and underpins an increased risk of age-related co-morbidities. We assessed the Frailty Index in older HIV+ Australian men on ART. Immunometabolic markers on monocytes and T cells were analyzed using flow cytometry, plasma innate immune activation markers by ELISA, and lipidomic profiling by mass spectrometry. The study population consisted of 80 HIV. + men with a median age of 59 (IQR, 56-65), and most had an undetectable viral load (92%). 24% were frail, and 76% were non-frail. Frailty was associated with elevated Glucose transporter-1 (Glut1) expression on the total monocytes (p = 0.04), increased plasma levels of innate immune activation marker sCD163 (OR, 4.8; CI 1.4-15.9, p = 0.01), phosphatidylethanolamine PE(36:3) (OR, 5.1; CI 1.7-15.5, p = 0.004) and triacylglycerol TG(16:1_18:1_18:1) (OR, 3.4; CI 1.3-9.2, p = 0.02), but decreased expression of GM3 ganglioside, GM3(d18:1/18:0) (OR, 0.1; CI 0.0-0.6, p = 0.01) and monohexosylceramide HexCerd(d18:1/22:0) (OR, 0.1; CI 0.0-0.5, p = 0.004). There is a strong inverse correlation between quality of life and the concentration of PE(36:3) (ρ = -0.33, p = 0.004) and PE(36:4) (ρ = -0.37, p = 0.001). These data suggest that frailty is associated with increased innate immune activation and abnormal lipidomic profile. These markers should be investigated in larger, longitudinal studies to determine their potential as biomarkers for frailty.

AB - Chronic immune activation persists despite antiretroviral therapy (ART) in HIV+ individuals and underpins an increased risk of age-related co-morbidities. We assessed the Frailty Index in older HIV+ Australian men on ART. Immunometabolic markers on monocytes and T cells were analyzed using flow cytometry, plasma innate immune activation markers by ELISA, and lipidomic profiling by mass spectrometry. The study population consisted of 80 HIV. + men with a median age of 59 (IQR, 56-65), and most had an undetectable viral load (92%). 24% were frail, and 76% were non-frail. Frailty was associated with elevated Glucose transporter-1 (Glut1) expression on the total monocytes (p = 0.04), increased plasma levels of innate immune activation marker sCD163 (OR, 4.8; CI 1.4-15.9, p = 0.01), phosphatidylethanolamine PE(36:3) (OR, 5.1; CI 1.7-15.5, p = 0.004) and triacylglycerol TG(16:1_18:1_18:1) (OR, 3.4; CI 1.3-9.2, p = 0.02), but decreased expression of GM3 ganglioside, GM3(d18:1/18:0) (OR, 0.1; CI 0.0-0.6, p = 0.01) and monohexosylceramide HexCerd(d18:1/22:0) (OR, 0.1; CI 0.0-0.5, p = 0.004). There is a strong inverse correlation between quality of life and the concentration of PE(36:3) (ρ = -0.33, p = 0.004) and PE(36:4) (ρ = -0.37, p = 0.001). These data suggest that frailty is associated with increased innate immune activation and abnormal lipidomic profile. These markers should be investigated in larger, longitudinal studies to determine their potential as biomarkers for frailty.

KW - Aging

KW - Frailty

KW - Glut1

KW - HIV

KW - Immunometabolism

KW - Inflammation

KW - Lipids

KW - Metabolism

KW - Monocytes

UR - http://www.scopus.com/inward/record.url?scp=85025694076&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2017.07.015

DO - 10.1016/j.ebiom.2017.07.015

M3 - Article

VL - 22

SP - 112

EP - 121

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

ER -